Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Barrett

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2018
Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's DiseaseKathryn A Wyman-Chick, Phillip K Martin, Daniel Weintraub, et al.
Neurology|August 31, 2018
Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of lifeScott A Sperling, Binit B Shah, Matthew J Barrett, et al.
Neurology. Clinical Practice|October 14, 2024
Distinguishing Prodromal Dementia With Lewy Bodies From Prodromal Alzheimer Disease: A Longitudinal StudyKathryn A Wyman-Chick, Tanis J Ferman, Daniel Weintraub, et al.
Journal of Geriatric Psychiatry and Neurology|June 11, 2021
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia OnsetKathryn A Wyman-Chick, Lauren R O'Keefe, Daniel Weintraub, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 21, 2025
Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodiesRachel J Heo, Ahmed Negida, Kathryn A Wyman-Chick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2019
Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson diseaseMatthew J Barrett, Scott A Sperling, Jamie C Blair, et al.
CNS Neuroscience & Therapeutics|February 9, 2024
Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysisAhmed Negida, Nafisa M Hassan, Heba Aboeldahab, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center dataKathryn A Wyman-Chick, Tanis J Ferman, Melissa J Armstrong, et al.
Frontiers in Aging Neuroscience|November 22, 2024
Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal studyJoseph L Flanigan, Madaline B Harrison, James T Patrie, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 2, 2019
Comparison of Parkinson's Disease Patients' Characteristics by Indication for Deep Brain Stimulation: Men Are More Likely to Have DBS for TremorW Alex Dalrymple, Antonia Pusso, Scott A Sperling, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2018
Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's DiseaseKathryn A Wyman-Chick, Phillip K Martin, Daniel Weintraub, et al.
Neurology|August 31, 2018
Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of lifeScott A Sperling, Binit B Shah, Matthew J Barrett, et al.
Neurology. Clinical Practice|October 14, 2024
Distinguishing Prodromal Dementia With Lewy Bodies From Prodromal Alzheimer Disease: A Longitudinal StudyKathryn A Wyman-Chick, Tanis J Ferman, Daniel Weintraub, et al.
Journal of Geriatric Psychiatry and Neurology|June 11, 2021
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia OnsetKathryn A Wyman-Chick, Lauren R O'Keefe, Daniel Weintraub, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 21, 2025
Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodiesRachel J Heo, Ahmed Negida, Kathryn A Wyman-Chick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2019
Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson diseaseMatthew J Barrett, Scott A Sperling, Jamie C Blair, et al.
CNS Neuroscience & Therapeutics|February 9, 2024
Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysisAhmed Negida, Nafisa M Hassan, Heba Aboeldahab, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center dataKathryn A Wyman-Chick, Tanis J Ferman, Melissa J Armstrong, et al.
Frontiers in Aging Neuroscience|November 22, 2024
Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal studyJoseph L Flanigan, Madaline B Harrison, James T Patrie, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 2, 2019
Comparison of Parkinson's Disease Patients' Characteristics by Indication for Deep Brain Stimulation: Men Are More Likely to Have DBS for TremorW Alex Dalrymple, Antonia Pusso, Scott A Sperling, et al.
Pageof 8